Heparin Market Size, Share & Trends Analysis Report By Type (Low Molecular Weight, Ultra-low Molecule Weight), By Route of Administration, By Application Form, By End Use, And Segment Forecasts, 2019 - 2026

Published: Jul, 2019 | Pages: 80 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global heparin market size is expected to reach USD 7.4 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 1.6% during the forecast period. Rising prevalence cardiovascular disorders, deep vein thrombosis, and renal diseases among other chronic diseases is expected to boost the growth.

According to the data published in the American Heart Association, in 2018, approximately 92.1 million American adults were living with some form of cardiovascular diseases. Coronary heart disease is one of the leading cause of deaths in U.S. Furthermore, it was estimated that more than 23.6 million deaths will be observed by 2030 due to cardiovascular diseases.

Increasing demand for transfusion of blood, blood components, and plasma derivatives during surgical procedures, treatment of infectious diseases, and increasing survival rate are high impact rendering drivers for growth of the heparin market during the forecast period. Increasing demand for RBCs and platelets by various hospital divisions and clinics is expected to have a positive impact on the growth.

Growing geriatric population is anticipated to propel the market growth. According to an article published in 2018 in the United States Census Bureau, it is estimated that by 2035, population aged 65 years and above is expected to reach 78 million whereas children under the age of 18 may reach around 76.7million.

Rising incidence of immunological diseases, thrombosis, and hemostasis is likely to result in high demand for therapeutic plasma proteins. Manufacturing of plasma proteins led to an increase in the demand for purified plasma, further expected to fuel the market over the forecast period.

Further key findings from the report suggest:

• Low molecular weight heparin led the type segment in 2018 owing to its more predictable anticoagulant effect

• In 2018, ultra-low molecular weight heparin was estimated to be the fastest growing segment, owing to commercialization of enhanced version of products with improved pharmacological effects

• Subcutaneous route of administration led the market in 2018 and is estimated to be the fastest growing segment over the forecast period due to ease of administration

• Coronary artery disease was considered to be the largest application segment in 2018 and venous thromboembolism is projected to be the fastest growing segment in near future

• In 2018, outpatient led the end use segment and was estimated to register the fastest growth in the forthcoming years

• North America held the largest market share in 2018 owing to increasing prevalence of cardiovascular disorders and sports injuries. Asia Pacific is estimated to be the fastest growing segment over the forecast period

• Some of the key companies operating in the heparin market are GlaxoSmithKline plc; Pfizer, Inc.; Baxter; Leo Pharma A/S; Sanofi; Dr. Reddy's Laboratories Ltd.; Aspen Holdings; B. Braun Medical Inc.; Fresenius SE & Co. KGaA; and Teva Pharmaceutical Industries Ltd

 Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Market Segmentation & Scope
                  1.2. Market Definition
                  1.3. Information Procurement
                      1.3.1. Purchased Database
                      1.3.2. GVR's Internal Database
                      1.3.3. Secondary sources & third-party perspectives
                      1.3.4. Primary research
                  1.4. Information Analysis
                      1.4.1. Data Analysis Models
                  1.5. Market Formulation & Data Visualization
                  1.6. Data Validation & Publishing
Chapter 2. Executive Summary
                  2.1. Market Outlook 
                  2.2. Segment Outlook 
                  2.3. Competitive Insights
Chapter 3. Global Heparin Market Variables, Trends & Scope
                  3.1. Heparin Market Lineage Outlook
                      3.1.1. Related/Ancillary Market Outlook
                  3.2. Penetration & Growth Prospect Mapping
                  3.3. Market Dynamics
                      3.3.1. Market Driver Analysis
                          3.3.1.1. Increasing prevalence of chronic diseases
                          3.3.1.2. Growing demand for whole blood and blood components transfusion
                          3.3.1.3. Increasing geriatric population
                          3.3.1.4. Increasing usage of plasma in pharmaceutical industry
                      3.3.2. Market Restraint Analysis
                          3.3.2.1. Risk of blood transmitted diseases and increasing number of blood substitutes
                          3.3.2.2. Emerging of oral anticoagulants
                  3.4. Heparin Market Analysis Tools
                      3.4.1. Industry Analysis - Porter's
                          3.4.1.1. Supplier Power: Moderate due to presence of many suppliers
                          3.4.1.2. Buyer Power: Moderate owing to presence of providers
                          3.4.1.3. Substitution Threat: High owing to adoption of oral anticoagulants 
                          3.4.1.4. Threat from New Entrant: Moderate due to high buyer switching cost
                          3.4.1.5. Competitive Rivalry: Low due to changing market dynamics towards oral anticoagulants
                  3.5. PESTEL Analysis
                      3.5.1. Political Landscape
                      3.5.2. Environmental Landscape
                      3.5.3. Social Landscape
                      3.5.4. Technology Landscape
                      3.5.5. Legal Landscape
Chapter 4. Heparin Market: Type Estimates & Trend Analysis 
                  4.1. Definitions & Scope 
                  4.2. Type Market Share Analysis, 2018 & 2026
                  4.3. Type Dashboard 
                  4.4. Global Heparin Market, By Type, 2014 To 2026
                  4.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
                      4.5.1. Low Molecular Weight Heparin
                          4.5.1.1. Low molecular weight heparin market, 2014 - 2026 (USD Million)
                          4.5.1.2. Intravenous 
                              4.5.1.2.1. Intravenous market, 2014 - 2026 (USD Million)
                          4.5.1.3. Subcutaneous 
                              4.5.1.3.1. Subcutaneous market, 2014 - 2026 (USD Million)
                      4.5.2. Ultra-low Molecular Weight Heparin 
                          4.5.2.1. Ultra-low molecular weight heparin market, 2014 - 2026 (USD Million)
                          4.5.2.2. Intravenous 
                              4.5.2.2.1. Intravenous market, 2014 - 2026 (USD Million)
                          4.5.2.3. Subcutaneous 
                              4.5.2.3.1. Subcutaneous market, 2014 - 2026 (USD Million)
                      4.5.3. Unfractionated Heparin
                          4.5.3.1. Unfractionated heparin market, 2014 - 2026 (USD Million)
                          4.5.3.2. Intravenous 
                              4.5.3.2.1. Intravenous market, 2014 - 2026 (USD Million)
                          4.5.3.3. Subcutaneous 
                              4.5.3.3.1. Subcutaneous market, 2014 - 2026 (USD Million)
Chapter 5. Heparin Market: Route of Administration Estimates & Trend Analysis
                  5.1. Definitions & Scope 
                  5.2. Route of Administration Market Share Analysis, 2018 & 2026
                  5.3. Route of Administration Dashboard 
                  5.4. Global Heparin Market, By Route of Administration, 2014 To 2026
                  5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
                      5.5.1. Intravenous 
                          5.5.1.1. Intravenous market, 2014 - 2026 (USD Million)
                      5.5.2. Subcutaneous 
                          5.5.2.1. Subcutaneous market, 2014 - 2026 (USD Million)
Chapter 6. Heparin Market: Application Estimates & Trend Analysis 
                  6.1. Definitions & Scope 
                  6.2. Application Market Share Analysis, 2018 & 2026
                  6.3. Application Dashboard 
                  6.4. Global Heparin Market, By Application, 2014 To 2026
                  6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
                      6.5.1. Venous Thromboembolism
                          6.5.1.1. Venous thromboembolism market, 2014 - 2026 (USD Million)
                      6.5.2. Atrial Fibrillation
                          6.5.2.1. Atrial fibrillation market, 2014 - 2026 (USD Million)
                      6.5.3. Renal Impairment 
                          6.5.3.1. Renal impairment market, 2014 - 2026 (USD Million)
                      6.5.4. Coronary Artery Disease
                          6.5.4.1. Coronary artery disease market, 2014 - 2026 (USD Million)
                      6.5.5. Others
                          6.5.5.1. Others market, 2014 - 2026 (USD Million)
Chapter 7. Heparin Market: End use Estimates & Trend Analysis 
                  7.1. Definitions & Scope 
                  7.2. End use Market Share Analysis, 2018 & 2026
                  7.3. End use Dashboard 
                  7.4. Global Heparin Market, By End use, 2014 To 2026
                  7.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
                      7.5.1. Outpatient 
                          7.5.1.1. Outpatient market, 2014 - 2026 (USD Million)
                      7.5.2. Inpatient
                          7.5.2.1. Inpatient market, 2014 - 2026 (USD Million)
Chapter 8. Heparin Market: Regional Estimates & Trend analysis, by type, route of administration, application and end use
                  8.1. Regional Market Snapshot 
                  8.2. Regional Market Share and Leading Players, 2018
                      8.2.1. North America
                      8.2.2. Europe
                      8.2.3. Asia Pacific
                      8.2.4. Latin America
                      8.2.5. Middle East & Africa
                  8.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
                      8.3.1. North America 
                      8.3.2. Europe
                      8.3.3. Asia Pacific
                      8.3.4. Latin America
                      8.3.5. Middle East & Africa
                  8.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026:
                      8.4.1. North America 
                          8.4.1.1. North America heparin market, 2014 - 2026 (USD Million)
                          8.4.1.2. U.S.
                              8.4.1.2.1. U.S. heparin market, 2014 - 2026 (USD Million)
                          8.4.1.3. Canada
                              8.4.1.3.1. Canada heparin market, 2014 - 2026 (USD Million)
                      8.4.2. Europe
                          8.4.2.1. Europe heparin market, 2014 - 2026 (USD Million)
                          8.4.2.2. U.K.
                              8.4.2.2.1. U.K. heparin market, 2014 - 2026 (USD Million)
                          8.4.2.3. Germany
                              8.4.2.3.1. Germany heparin market, 2014 - 2026 (USD Million)
                          8.4.2.4. Spain
                              8.4.2.4.1. Spain heparin market, 2014 - 2026 (USD Million)
                          8.4.2.5. France
                              8.4.2.5.1. France heparin market, 2014 - 2026 (USD Million)
                          8.4.2.6. Italy
                              8.4.2.6.1. Italy heparin market, 2014 - 2026 (USD Million)
                          8.4.2.7. Russia
                              8.4.2.7.1. Russia heparin market, 2014 - 2026 (USD Million)
                      8.4.3. Asia Pacific
                          8.4.3.1. Asia Pacific heparin market, 2014 - 2026 (USD Million)
                          8.4.3.2. China
                              8.4.3.2.1. China heparin market, 2014 - 2026 (USD Million)
                          8.4.3.3. Japan
                              8.4.3.3.1. Japan heparin market, 2014 - 2026 (USD Million)
                          8.4.3.4. India
                              8.4.3.4.1. India heparin market, 2014 - 2026 (USD Million)
                          8.4.3.5. South Korea
                              8.4.3.5.1. South Korea heparin market, 2014 - 2026 (USD Million)
                          8.4.3.6. Singapore
                              8.4.3.6.1. Singapore heparin market, 2014 - 2026 (USD Million)
                          8.4.3.7. Australia
                              8.4.3.7.1. Australia heparin market, 2014 - 2026 (USD Million)
                      8.4.4. Latin America
                          8.4.4.1. Latin America heparin market, 2014 - 2026 (USD Million)
                          8.4.4.2. Brazil
                              8.4.4.2.1. Brazil heparin market, 2014 - 2026 (USD Million)
                          8.4.4.3. Mexico
                              8.4.4.3.1. Mexico heparin market, 2014 - 2026 (USD Million)
                          8.4.4.4. Argentina
                              8.4.4.4.1. Argentina heparin market, 2014 - 2026 (USD Million)
                      8.4.5. Middle East Africa
                          8.4.5.1. MEA heparin market, 2014 - 2026 (USD Million)
                          8.4.5.2. South Africa
                              8.4.5.2.1. South Africa heparin market, 2014 - 2026 (USD Million)
                          8.4.5.3. Saudi Arabia
                              8.4.5.3.1. Saudi Arabia heparin market, 2014 - 2026 (USD Million)
                          8.4.5.4. UAE
                              8.4.5.4.1. UAE heparin market, 2014 - 2026 (USD Million)
Chapter 9. Company Profiles
                  9.1. Recent Developments & Impact Analysis, By Key Market Participants
                  9.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                  9.3. Public Companies
                      9.3.1. Company Market Position Analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                      9.3.2. Competitive Dashboard Analysis 
                      9.3.3. Market Differentiators 
                  9.4. Private Companies 
                      9.4.1. Regional Network Map
                  9.5. Strategic Framework
                      9.5.1. GlaxoSmithKline plc (GSK)
                          9.5.1.1. Company Overview
                          9.5.1.2. Financial Performance
                          9.5.1.3. Product Benchmarking
                          9.5.1.4. Strategic Initiatives
                      9.5.2. Pfizer Inc
                          9.5.2.1. Company Overview
                          9.5.2.2. Financial Performance
                          9.5.2.3. Product Benchmarking
                          9.5.2.4. Strategic Initiatives
                      9.5.3. LeoPharma A/S
                          9.5.3.1. Company Overview
                          9.5.3.2. Financial Performance
                          9.5.3.3. Product Benchmarking
                          9.5.3.4. Strategic Initiatives
                      9.5.4. Sanofi
                          9.5.4.1. Company Overview
                          9.5.4.2. Financial Performance
                          9.5.4.3. Product Benchmarking
                          9.5.4.4. Strategic Initiatives
                      9.5.5. Dr. Reddy's Laboratories Ltd.
                          9.5.5.1. Company Overview
                          9.5.5.2. Financial Performance
                          9.5.5.3. Product Benchmarking
                          9.5.5.4. Strategic Initiatives
                      9.5.6. Aspen Holdings
                          9.5.6.1. Company Overview
                          9.5.6.2. Financial Performance
                          9.5.6.3. Product Benchmarking
                          9.5.6.4. Strategic Initiatives
                      9.5.7. B. Braun Medical Inc.
                          9.5.7.1. Company Overview
                          9.5.7.2. Financial Performance
                          9.5.7.3. Product Benchmarking
                          9.5.7.4. Strategic Initiatives
                      9.5.8. Fresenius SE & Co. KGaA
                          9.5.8.1. Company Overview
                          9.5.8.2. Financial Performance
                          9.5.8.3. Product Benchmarking
                          9.5.8.4. Strategic Initiatives
                      9.5.9. Teva Pharmaceutical Industries Ltd.
                          9.5.9.1. Company Overview
                          9.5.9.2. Financial Performance
                          9.5.9.3. Product Benchmarking
                          9.5.9.4. Strategic Initiatives

List of Tables

TABLE 1 List of Abbreviation
TABLE 2 North America Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 3 North America Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 4 North America Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 5 North America Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 6 North America Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 7 North America Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 8 North America Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 9 U.S. Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 10 U.S. Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 11 U.S. Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 12 U.S. Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 13 U.S. Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 14 U.S. Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 15 U.S. Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 16 Canada Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 17 Canada Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 18 Canada Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 19 Canada Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 20 Canada Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 21 Canada Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 22 Canada Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 23 Europe Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 24 Europe Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 25 Europe Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 26 Europe Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 27 Europe Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 28 Europe Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 29 Europe Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 30 U.K. Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 31 U.K. Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 32 U.K. Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 33 U.K. Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 34 U.K. Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 35 U.K. Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 36 U.K. Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 37 Germany Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 38 Germany Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 39 Germany Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 40 Germany Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 41 Germany Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 42 Germany Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 43 Germany Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 44 France Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 45 France Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 46 France Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 47 France Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 48 France Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 49 France Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 50 France Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 51 Italy Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 52 Italy Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 53 Italy Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 54 Italy Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 55 Italy Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 56 Italy Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 57 Italy Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 58 Spain Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 59 Spain Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 60 Spain Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 61 Spain Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 62 Spain Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 63 Spain Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 64 Spain Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 65 Russia Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 66 Russia Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 67 Russia Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 68 Russia Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 69 Russia Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 70 Russia Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 71 Russia Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 72 Asia Pacific Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 73 Asia Pacific Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 74 Asia Pacific Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 75 Asia Pacific Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 76 Asia Pacific Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 77 Asia Pacific Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 78 Asia Pacific Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 79 Japan Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 80 Japan Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 81 Japan Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 82 Japan Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 83 Japan Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 84 Japan Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 85 Japan Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 86 India Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 87 India Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 88 India Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 89 India Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 90 India Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 91 India Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 92 India Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 93 South Korea Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 94 South Korea Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 95 South Korea Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 96 South Korea Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 97 South Korea Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 98 South Korea Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 99 South Korea Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 100 Australia Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 101 Australia Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 102 Australia Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 103 Australia Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 104 Australia Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 105 Australia Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 106 Australia Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 107 Singapore Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 108 Singapore Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 109 Singapore Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 110 Singapore Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 111 Singapore Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 112 Singapore Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 113 Singapore Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 114 Latin America Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 115 Latin America Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 116 Latin America Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 117 Latin America Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 118 Latin America Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 119 Latin America Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 120 Latin America Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 121 Brazil Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 122 Brazil Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 123 Brazil Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 124 Brazil Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 125 Brazil Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 126 Brazil Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 127 Brazil Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 128 Mexico Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 129 Mexico Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 130 Mexico Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 131 Mexico Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 132 Mexico Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 133 Mexico Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 134 Mexico Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 135 Argentina Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 136 Argentina Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 137 Argentina Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 138 Argentina Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 139 Argentina Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 140 Argentina Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 141 Argentina Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 142 MEA Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 143 MEA Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 144 MEA Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 145 MEA Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 146 MEA Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 147 MEA Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 148 MEA Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 149 South Africa Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 150 South Africa Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 151 South Africa Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 152 South Africa Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 153 South Africa Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 154 South Africa Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 155 South Africa Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 156 UAE Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 157 UAE Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 158 UAE Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 159 UAE Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 160 UAE Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 161 UAE Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 162 UAE Heparin Market, By End use, 2014 - 2026 (USD Million)
TABLE 163 Saudi Arabia Heparin Market, By Type, 2014 - 2026 (USD Million)
TABLE 164 Saudi Arabia Low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 165 Saudi Arabia Ultra-low Molecular Weight Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 166 Saudi Arabia Unfractionated Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 167 Saudi Arabia Heparin Market, By Route of Administration, 2014 - 2026 (USD Million)
TABLE 168 Saudi Arabia Heparin Market, By Application, 2014 - 2026 (USD Million)
TABLE 169 Saudi Arabia Heparin Market, By End use, 2014 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global heparin market - Key market driver analysis
FIG. 7 Global heparin market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Factors estimated to impact on market growth
FIG. 10 Global heparin market - Porter's analysis
FIG. 11 Global heparin market - PESTEL analysis
FIG. 12 Global heparin market type outlook key takeaways
FIG. 13 Global heparin market: Type movement analysis
FIG. 14 Low molecular weight heparin market estimates, 2014 - 2026 (USD Million)
FIG 15 Ultra-low molecular weight heparin market estimates, 2014 - 2026 (USD Million)
FIG 16 Unfractionated heparin market estimates, 2014 - 2026 (USD Million)
FIG. 17 Global heparin market route of administration outlook key takeaways
FIG. 18 Global heparin market: Route of Administration movement analysis
FIG. 19 Intravenous market estimates, 2014 - 2026 (USD Million)
FIG. 20 Subcutaneous market estimates, 2014 - 2026 (USD Million)
FIG. 21 Global heparin market application outlook key takeaways
FIG. 22 Global heparin market: Application movement analysis
FIG. 23 Venous thromboembolism market estimates, 2014 - 2026 (USD Million)
FIG. 24 Atrial fibrillation market estimates, 2014 - 2026 (USD Million)
FIG. 25 Renal impairment market estimates, 2014 - 2026 (USD Million)
FIG. 26 Coronary artery disease market estimates, 2014 - 2026 (USD Million)
FIG. 27 Others market estimates, 2014 - 2026 (USD Million)
FIG. 28 Global heparin market end use outlook key takeaways
FIG. 29 Global heparin market: End use movement analysis
FIG. 30 Outpatient market estimates, 2014 - 2026 (USD Million)
FIG. 31 Inpatient market estimates, 2014 - 2026 (USD Million)
FIG. 32 Regional market place: Key takeaways
FIG. 33 Global heparin market: Regional movement analysis
FIG. 34 North America heparin market, 2014 - 2026 (USD Million)
FIG. 35 U.S. heparin market, 2014 - 2026 (USD Million)
FIG. 36 Canada heparin market, 2014 - 2026 (USD Million)
FIG. 37 Europe heparin market, 2014 - 2026 (USD Million)
FIG. 38 U.K. heparin market, 2014 - 2026 (USD Million)
FIG. 39 Germany heparin market, 2014 - 2026 (USD Million)
FIG. 40 France heparin market, 2014 - 2026 (USD Million)
FIG. 41 Spain heparin market, 2014 - 2026 (USD Million)
FIG. 42 Italy heparin market, 2014 - 2026 (USD Million)
FIG. 43 Russia heparin market, 2014 - 2026 (USD Million)
FIG. 44 Asia Pacific heparin market, 2014 - 2026 (USD Million)
FIG. 45 Japan heparin market, 2014 - 2026 (USD Million)
FIG. 46 China heparin market, 2014 - 2026 (USD Million)
FIG. 47 India heparin market, 2014 - 2026 (USD Million)
FIG. 48 South Korea heparin market, 2014 - 2026 (USD Million)
FIG. 49 Singapore heparin market, 2014 - 2026 (USD Million)
FIG. 50 Australia heparin market, 2014 - 2026 (USD Million)
FIG. 51 Latin America heparin market, 2014 - 2026 (USD Million)
FIG. 52 Brazil heparin market, 2014 - 2026 (USD Million)
FIG. 53 Mexico heparin market, 2014 - 2026 (USD Million)
FIG. 54 Argentina heparin market, 2014 - 2026 (USD Million)
FIG. 55 MEA heparin market, 2014 - 2026 (USD Million)
FIG. 56 South Africa heparin market, 2014 - 2026 (USD Million)
FIG. 58 Saudi Arabia heparin market, 2014 - 2026 (USD Million)
FIG. 57 UAE market, 2014 - 2026 (USD Million)
FIG. 59 Strategy framework